Skip to main content

Screening for Coronavirus Antibodies in Neighborhoods (SCAN)


About the Study

Please note that this is not a vaccine trial and you will not receive any experimental drugs. Our team also understands that there may be distrust from communities that have been harmed and exploited by medical and research institutions. We take the safety of our participants and ethical research standards seriously. All of our studies are reviewed by an independent committee to protect participant rights and wellbeing. We are happy to speak to you about any specific concerns you may have about SCAN.

The purpose of the SCAN Study is to find out how many people in specific areas have been exposed to SARS-CoV-2 (also known as coronavirus or COVID-19) and developed antibodies to the virus. The SCAN Study will also help researchers learn if these antibodies protect people against re-infection.

We will test your blood for antibodies to SARS-CoV-2, the virus that causes COVID-19. The timing of antibodies appearing in the blood stream is not fully known, some appear sooner than others, and some people develop antibodies without having symptoms of disease. We will test for antibodies, including those that can remain in the blood for a long time. In other types of infection, these antibodies often indicate immunity or a sign that the body has recovered from infection.

If you are interested in joining the SCAN Study, please answer a few questions in the form below to find out if you are eligible. Your responses are voluntary and confidential. If you have any questions, please check our FAQ page for frequently asked questions and answers or please contact our team on our Contact Us page.

Sign Up!

If you are an FSM essential worker, please do not fill out the survey below. You will be invited to our study via email.